Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
0.6800
-0.0583 (-7.90%)
At close: Mar 31, 2025, 4:00 PM
0.6943
+0.0143 (2.11%)
Pre-market: Apr 1, 2025, 5:18 AM EDT
Nektar Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 44.25 | 35.28 | 88.23 | 25.22 | 198.96 | Upgrade
|
| Short-Term Investments | 210.97 | 268.34 | 416.75 | 708.74 | 862.94 | Upgrade
|
| Cash & Short-Term Investments | 255.23 | 303.62 | 504.98 | 733.96 | 1,062 | Upgrade
|
| Cash Growth | -15.94% | -39.88% | -31.20% | -30.88% | -19.85% | Upgrade
|
| Accounts Receivable | - | 1.21 | 5.98 | 22.49 | 38.89 | Upgrade
|
| Other Receivables | 1.61 | 1.05 | 2.42 | 1.4 | 5.1 | Upgrade
|
| Receivables | 1.61 | 2.25 | 8.4 | 23.89 | 43.99 | Upgrade
|
| Inventory | - | 16.1 | 19.2 | 15.8 | 15.29 | Upgrade
|
| Prepaid Expenses | 2.51 | 4.41 | 5.99 | - | - | Upgrade
|
| Other Current Assets | 1.95 | 4.33 | 7.4 | 21.93 | 16.83 | Upgrade
|
| Total Current Assets | 261.29 | 330.7 | 545.97 | 795.58 | 1,138 | Upgrade
|
| Property, Plant & Equipment | 11.82 | 36.86 | 85.89 | 177.54 | 186.14 | Upgrade
|
| Long-Term Investments | 26.09 | 25.83 | - | 64.83 | 136.66 | Upgrade
|
| Goodwill | - | - | 76.5 | 76.5 | 76.5 | Upgrade
|
| Other Long-Term Assets | 4.65 | 4.64 | 2.25 | 2.74 | 1.46 | Upgrade
|
| Total Assets | 303.85 | 398.03 | 710.6 | 1,117 | 1,539 | Upgrade
|
| Accounts Payable | 11.56 | 9.85 | 12.98 | 9.75 | 22.14 | Upgrade
|
| Accrued Expenses | 27.21 | 19.14 | 28.85 | 58.01 | 79.73 | Upgrade
|
| Current Portion of Leases | 19.87 | 19.26 | 18.67 | 17.44 | 13.92 | Upgrade
|
| Other Current Liabilities | 2.77 | 3.02 | 7.71 | - | - | Upgrade
|
| Total Current Liabilities | 61.4 | 51.27 | 68.2 | 85.2 | 115.78 | Upgrade
|
| Long-Term Debt | 91.78 | 112.63 | 155.38 | 195.43 | 200.34 | Upgrade
|
| Long-Term Leases | 82.7 | 98.52 | 112.83 | 125.74 | 136.37 | Upgrade
|
| Other Long-Term Liabilities | 7.24 | 4.64 | 7.55 | 31.32 | 8.98 | Upgrade
|
| Total Liabilities | 243.11 | 267.05 | 343.96 | 437.68 | 461.47 | Upgrade
|
| Common Stock | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 3,660 | 3,608 | 3,575 | 3,517 | 3,389 | Upgrade
|
| Retained Earnings | -3,596 | -3,477 | -3,201 | -2,833 | -2,309 | Upgrade
|
| Treasury Stock | -3 | - | - | - | - | Upgrade
|
| Comprehensive Income & Other | 0.06 | 0.08 | -6.91 | -4.16 | -2.3 | Upgrade
|
| Shareholders' Equity | 60.74 | 130.99 | 366.64 | 679.51 | 1,077 | Upgrade
|
| Total Liabilities & Equity | 303.85 | 398.03 | 710.6 | 1,117 | 1,539 | Upgrade
|
| Total Debt | 194.34 | 230.4 | 286.87 | 338.6 | 350.63 | Upgrade
|
| Net Cash (Debt) | 74.76 | 99.04 | 218.1 | 460.18 | 847.93 | Upgrade
|
| Net Cash Growth | -24.52% | -54.59% | -52.61% | -45.73% | -24.55% | Upgrade
|
| Net Cash Per Share | 0.36 | 0.52 | 1.17 | 2.51 | 4.75 | Upgrade
|
| Filing Date Shares Outstanding | 186.1 | 183.62 | 189.24 | 186.27 | 182.18 | Upgrade
|
| Total Common Shares Outstanding | 185.78 | 191.38 | 188.56 | 185.47 | 180.09 | Upgrade
|
| Working Capital | 199.89 | 279.43 | 477.76 | 710.38 | 1,022 | Upgrade
|
| Book Value Per Share | 0.33 | 0.68 | 1.94 | 3.66 | 5.98 | Upgrade
|
| Tangible Book Value | 60.74 | 130.99 | 290.14 | 603.01 | 1,001 | Upgrade
|
| Tangible Book Value Per Share | 0.33 | 0.68 | 1.54 | 3.25 | 5.56 | Upgrade
|
| Buildings | 3.88 | 43.18 | 74.89 | 97.39 | 92.98 | Upgrade
|
| Machinery | 15.2 | 61.83 | 79.76 | 104 | 100.47 | Upgrade
|
| Construction In Progress | 0.25 | 0.74 | 2.53 | 7.16 | 4.7 | Upgrade
|
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.